Companies: 10,795·Total market cap: $144.5T
Cipher Pharmaceuticals Inc.

Cipher Pharmaceuticals Inc.

CPH.TOTSXHealthcare● Active
$16.84
+$0.09(+0.54%)
Market Cap$427589862
P/E Ratio
52W High$20.56
52W Low$11.98

Cipher Pharmaceuticals Inc.(CPH.TO)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · CPH.TO · 截至 2026-06-08

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$51.33M$33.36M$21.16M$20.68M$21.94M
Cost of Revenue$17.56M$9.26M$4.07M$3.99M$3.68M
Gross Profit$33.77M$24.10M$17.09M$16.68M$18.26M
Gross Margin %(computed)65.79%72.24%80.77%80.69%83.21%
Operating Expenses
R&D Expenses$0.00M$0.00M$0.14M$0.10M$0.09M
G&A Expenses$0.00M$10.69M$4.67M$3.90M$0.00M
Total Operating Expenses$16.97M$16.25M$5.56M$5.63M$6.45M
Operating Income$16.80M$7.85M$11.53M$12.04M$11.82M
Operating Margin %(computed)32.73%23.52%54.48%58.23%53.87%
Interest Income$0.00M$0.33M$1.87M$0.46M$0.01M
Interest Expense$1.19M$0.00M$0.00M$0.00M$0.09M
Income Before Tax$17.46M$2.96M$12.68M$11.48M$11.06M
Income Tax Expense($10.34M)($8.59M)($7.70M)($15.16M)$3.30M
Net Income$27.81M$11.54M$20.38M$26.64M$7.76M
Net Margin %(computed)54.17%34.60%96.32%128.83%35.36%
Per Share & EBITDA
EPS (Basic)$1.09$0.47$0.80$1.06$0.29
Wtd Avg Shares25.48M24.72M25.48M25.13M26.60M
EBITDA$16.80M$11.87M$11.53M$12.04M$13.66M
EBITDA Margin %(computed)32.73%35.56%54.48%58.23%62.25%

数据来源:Financial Modeling Prep · 最后更新:2026-06-08 · USD · M

深入了解Cipher Pharmaceuticals Inc.

关于Cipher Pharmaceuticals Inc.(CPH.TO)损益表

Cipher Pharmaceuticals Inc.(CPH.TO)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,CPH.TO实现营收$0.05B,毛利润$0.03B(毛利率65.79%),净利润$0.03B(净利率54.17%)。

常见问题

CPH.TO · 4 问

Cipher Pharmaceuticals Inc.(CPH.TO)2025财年营收为$0.05B,同比up53.9%。

CPH.TO revenueCPH.TO salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08